Trial intelligence / Profile preview

Meningeal Lymphatic Vessels in Chronic Subdural Hematoma Absorption

NCT05426889Unknown

Sponsor
Second Affiliated Hospital of Zhejiang University School of Medicine
Start
May 2022
Primary completion
Dec 2023
Countries
1
01

Overview

Open-label trial in chronic subdural hematoma (CSDH) (2 arms), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Primary endpoint: Magnetic resonance signal intensity of meningeal lymphatic vessels at 6 months. Status: unknown.

02

Conditions

chronic subdural hematoma (CSDH)

Beyond the preview

Go deeper on NCT05426889.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05426889.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call